Dailyglim PM 1 Tablet SR
Marketer
Leeford Healthcare Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Dailyglim PM 1 Tablet SR
Glimepiride and Metformin Extended-Release tablets offer a dual approach to managing blood glucose. This medication, used alongside diet and exercise, assists adults with type 2 diabetes in achieving better glycemic control. It enhances insulin effectiveness, resulting in reduced blood sugar. Dosage and frequency should strictly follow your physician's instructions. Take this medication with food to minimize gastrointestinal discomfort. If a dose is missed, take it promptly unless the next dose is imminent; in that case, skip the missed dose and resume your regular schedule. Never double the dose. Overdosage can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol consumption, or meal skipping may increase the risk of hypoglycemia. Regular blood sugar monitoring is essential. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Patients with kidney, liver, or heart conditions should disclose this information to their doctor prior to commencing treatment. Pregnant or lactating individuals require medical consultation before use. Kidney function will be assessed by your doctor before prescription. Limit alcohol consumption while taking this medication to mitigate potential side effects.
Primary Ingredients of Dailyglim PM 1 Tablet SR
There is no text provided to rephrase.
Uses of Dailyglim PM 1 Tablet SR
Managing Type 2 Diabetes
Major Benefits of Dailyglim PM 1 Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Take one Dailyglim PM sustained-release tablet with a meal.
Common Side effects of Dailyglim PM 1 Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Dailyglim PM 1 Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Dailyglim PM 1 Tablet SR with a meal.
How Dailyglim PM 1 Tablet SR works:
Dailyglim PM 1 Tablet SR combines three distinct antidiabetic agents—glimepiride, metformin, and pioglitazone—to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, retarding intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Dailyglim PM 1 Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Dailyglim PM 1 Tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to any prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Dailyglim PM 1 Tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with impaired kidney function should use Dailyglim PM 1 Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Physician consultation is essential. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Dailyglim PM 1 Tablet SR cautiously, potentially requiring dosage modification under medical supervision. The medication is contraindicated for individuals with severe hepatic dysfunction.
What if you forget to take Dailyglim PM 1 Tablet SR :
Should you forget a Dailyglim PM 1 Tablet SR dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Dailyglim PM 1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently